Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Dialysis

NCT01277510 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01277510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01277510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Dialysis
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Terminated
Start date
June 28, 2011
Completion date
Not reported
Enrollment
43 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hyperparathyroidism, hyperparathyroidism, secondary, kidney disease, secondary hyperparathyroidism